DSpace

DSpace at RU >

Search Results

 
for  

Results 1-50 of 88.

Sort items by In order  |  Results/Page Authors/record

Item hits:

Full TextIssue DateTitleAuthor(s)
2012Een proef over-levenRongen, Gerard
2012Local and remote ischemic postconditionings have synergistic protective effects on renal ischemia-reperfusion injury.Wever, K.E.; Menting, T.; Masereeuw, R.; Vliet, J.A. van der; Rongen, G.A.P.J.M.; Warle, M.C.
2012Targeting adenosine receptors in the development of cardiovascular therapeutics.Riksen, N.P.; Rongen, G.A.P.J.M.
2012Short-term statin treatment does not prevent ischemia and reperfusion-induced endothelial dysfunction in humans.Wouters, C.W.; Wever, K.E.; Bronckers, I.M.; Hopman, M.T.E.; Smits, P.; Thijssen, D.H.J.; Rongen, G.A.P.J.M.
2012Atorvastatin does not affect ischaemia-induced phosphatidylserine exposition in humans in-vivo.Wouters, C.W.; Meijer, P.; Janssen, C.I.F.; Frederix, G.W.; Oyen, W.J.G.; Boerman, O.C.; Smits, P.; Rongen, G.A.P.J.M.
2012How systemic inflammation modulates adenosine metabolism and adenosine receptor expression in humans in vivo.Ramakers, B.P.C.; Wever, K.E.; Kox, M.; Broek, P.L.C. van den; Mbuyi, F.; Rongen, G.A.; Masereeuw, R.; Hoeven, J.G. van der; Smits, P.; Riksen, N.P.; Pickkers, P.
2012Ischemic preconditioning in the animal kidney, a systematic review and meta-analysis.Wever, K.E.; Menting, T.P.; Rovers, M.M.; Vliet, J.A. van der; Rongen, G.A.P.J.M.; Masereeuw, R.; Ritskes-Hoitinga, M.; Hooijmans, C.R.; Warle, M.C.
2012Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot studyEngbersen, R.; Riksen, N.P.; Mol, M.J.T.M.; Bravenboer, B.; Boerman, O.C.; Meijer, P.; Oyen, W.J.G.; Tack, C.J.; Rongen, G.A.P.J.M.; Smits, P.
2011NT5E mutations and arterial calcificationsRiksen, N.P.; Rongen, G.A.P.J.M.
2011[Hypersenisitivity to low molecular weight heparins: diagnostics and management.] Article in Dutch.Valk, P.G. van der; Jansen, A.P.H.; Klasen, I.S.; Rongen, G.A.; Valk, J.P.M. van der
2011Pharmacogenetics: from bench to byte--an update of guidelinesSwen, J.J.; Nijenhuis, M.; Boer, A. de; Grandia, L.; Maitland-van der Zee, A.H.; Mulder, H.; Rongen, G.A.P.J.M.; Schaik, R.H. van; Schalekamp, T.; Touw, D.J.; Weide, J. van der; Wilffert, B.; Deneer, V.H.; Guchelaar, H.J.
2011The cardioprotective effects of metforminEl Messaoudi, S.; Rongen, G.A.P.J.M.; Boer, R.A. de; Riksen, N.P.
2011Reflex systemic sympatho-neural response to brachial adenosine infusion in treated heart failureWijeysundera, H.C.; Parmar, G.; Rongen, G.A.P.J.M.; Floras, J.S.
2011The cardiovascular effects of methylxanthinesRiksen, N.P.; Smits, P.; Rongen, G.A.P.J.M.
2011Angiotensin II type 1 receptor blockade does not enhance apoptotic cell death during ischemia and reperfusion in humans in vivoMeijer, P.; Wouters, C.W.; Oyen, W.J.G.; Boerman, O.C.; Scheffer, G.J.; Smits, P.; Rongen, G.A.P.J.M.
2011Remote ischaemic preconditioning by brief hind limb ischaemia protects against renal ischaemia-reperfusion injury: the role of adenosineWever, K.E.; Warle, M.C.; Wagener, F.A.D.T.G.; Hoorn, J.W. van der; Masereeuw, R.; Vliet, J.A. van der; Rongen, G.A.P.J.M.
2011Diannexin protects against renal ischemia reperfusion injury and targets phosphatidylserines in ischemic tissueWever, K.E.; Wagener, F.A.D.T.G.; Frielink, C.; Boerman, O.C.; Scheffer, G.J.; Allison, A.; Masereeuw, R.; Rongen, G.A.P.J.M.
2010Rosiglitazone reduces ischaemia-reperfusion injury in patients with the metabolic syndrome.Rennings, A.J.M.; Meijer, P.; Uden, D.J. van; Tack, C.J.J.; Smits, P.; Boerman, O.C.; Oyen, W.J.G.; Rongen, G.A.P.J.M.
2010Angiotensin II contributes to the increased baseline leg vascular resistance in spinal cord-injured individuals.Groothuis, J.T.; Thijssen, D.H.J.; Rongen, G.A.P.J.M.; Deinum, J.; Danser, A.H.; Geurts, A.C.H.; Smits, P.; Hopman, M.T.E.
2010Sympathetic nonadrenergic transmission contributes to autonomic dysreflexia in spinal cord-injured individuals.Groothuis, J.T.; Rongen, G.A.P.J.M.; Deinum, J.; Pickkers, P.; Danser, A.H.; Geurts, A.C.H.; Smits, P.; Hopman, M.T.E.
2010Effect of different sympathetic stimuli-autonomic dysreflexia and head-up tilt-on leg vascular resistance in spinal cord injury.Groothuis, J.T.; Rongen, G.A.P.J.M.; Geurts, A.C.H.; Smits, P.; Hopman, M.T.E.
2010Upregulation of ecto-5'-nucleotidase by rosuvastatin increases the vasodilator response to ischemia.Meijer, P.; Wouters, C.W.; Broek, P.H.H. van den; Rooij, M. de; Scheffer, G.J.; Smits, P.; Rongen, G.A.P.J.M.
2009De opkomst van nieuwe methoden om ischemie-reperfusieschade te verminderenRiksen, N.P.; Rongen, G.A.P.J.M.
2009The Dutch vision of clinical pharmacology.Schellens, J.H.; Grouls, R.; Guchelaar, H.J.; Touw, D.J.; Rongen, G.A.P.J.M.; Boer, A.J. de; Bortel, L.M. van
2009Acute and long-term cardiovascular effects of coffee: implications for coronary heart disease.Riksen, N.P.; Rongen, G.A.P.J.M.; Smits, P.
2009Metformin prevents myocardial reperfusion injury by activating the adenosine receptor.Paiva, M.; Riksen, N.P.; Davidson, S.M.; Hausenloy, D.J.; Monteiro, P.; Goncalves, L.; Providencia, L.; Rongen, G.A.P.J.M.; Smits, P.; Mocanu, M.M.; Yellon, D.M.
2009The role of the alpha-adrenergic receptor in the leg vasoconstrictor response to orthostatic stress.Kooijman, M.; Rongen, G.A.P.J.M.; Smits, P.; Kuppevelt, H.J.M. van; Hopman, M.T.E.
2009Endotoxin tolerance does not limit mild ischemia-reperfusion injury in humans in vivo.Draisma, A.; Goeij, M. de; Wouters, C.W.; Riksen, N.P.; Oyen, W.J.G.; Rongen, G.A.P.J.M.; Boerman, O.C.; Deuren, M. van; Hoeven, J.G. van der; Pickkers, P.
2009Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection.Meijer, P.; Oyen, W.J.G.; Dekker, D.; Broek, P.H.H. van den; Wouters, C.W.; Boerman, O.C.; Scheffer, G.J.; Smits, P.; Rongen, G.A.P.J.M.
2008The Dutch model for clinical pharmacology: collaboration between physician- and pharmacist--clinical pharmacologists.Schellens, J.H.M.; Grouls, R.; Guchelaar, H.J.; Touw, D.J.; Rongen, G.A.P.J.M.; Boer, A. de; Bortel, L.M. van
2008Measurement of the endogenous adenosine concentration in humans in vivo: methodological considerations.Ramakers, B.P.C.; Pickkers, P.; Deussen, A.; Rongen, G.A.P.J.M.; Broek, P. van den; Hoeven, J.G. van der; Smits, P.; Riksen, N.P.
2008Human in vivo research on the vascular effects of adenosine.Riksen, N.P.; Rongen, G.A.P.J.M.; Yellon, D.; Smits, P.
2008The effect of atazanavir and atazanavir/ritonavir on UDP-glucuronosyltransferase using lamotrigine as a phenotypic probe.Burger, D.M.; Huisman, A.; Ewijk, N. van; Neisingh, H.; Uden, P. van; Rongen, G.A.P.J.M.; Koopmans, P.; Bertz, R.J.
2008Physical (in)activity and endothelium-derived constricting factors: overlooked adaptations.Thijssen, D.H.J.; Rongen, G.A.P.J.M.; Smits, P.; Hopman, M.T.E.
2008The 22G>A polymorphism in the adenosine deaminase gene impairs catalytic function but does not affect reactive hyperaemia in humans in vivo.Riksen, N.P.; Franke, B.; Broek, P. van den; Naber, M.; Smits, P.; Rongen, G.A.P.J.M.
2008Flow-mediated dilatation in the superficial femoral artery is nitric oxide mediated in humans.Kooijman, M.; Thijssen, D.H.J.; Groot, P.C.E. de; Bleeker, M.W.P.; Kuppevelt, H.J.M. van; Green, D.J.; Rongen, G.A.P.J.M.; Smits, P.; Hopman, M.T.E.
2008Dipyridamole enhances ischaemia-induced reactive hyperaemia by increased adenosine receptor stimulation.Meijer, P.; Wouters, C.W.; Broek, Philip van den; Scheffer, G.J.; Riksen, N.P.; Smits, P.; Rongen, G.A.P.J.M.
2008High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets.Nijland, H.M.J.; L'homme, R.F.A.; Rongen, G.A.P.J.M.; Uden, P. van; Crevel, R. van; Boeree, M.J.; Aarnoutse, R.E.; Koopmans, P.P.; Burger, D.M.
2007Fever and cough in a patient with diabetes. Empyema caused by S. typhimurium.Ropela, J.A.; Die, L. van; Oyen, W.J.G.; Rongen, G.A.
2007Effect of the 34C>T variant in the AMPD1 gene on the clinical response to methotrexate in patients with rheumatoid arthritis: comment on the article by Wessels et al.Riksen, N.P.; Rongen, G.A.; Smits, P.; Riel, P.L.C.M. van; Barrera, P.
2007[Subglottal stenosis as the first symptom of Wegener's granulomatosis]Verhaegen, V.J.O.; Rongen, G.A.; Marres, H.A.M.
2007Leg blood flow measurements using venous occlusion plethysmography during head-up tilt.Kooijman, M.; Poelkens, F.; Rongen, G.A.; Smits, P.; Hopman, M.T.E.
2007The 1976C>T polymorphism in the adenosine A2A receptor gene does not affect the vasodilator response to adenosine in humans in vivoRiksen, N.P.; Franke, B.; Broek, P. van den; Smits, P.; Rongen, G.A.
2007Enhanced endothelin-1-mediated leg vascular tone in healthy older subjects.Thijssen, D.H.J.; Rongen, G.A.; Dijk, A. van; Smits, P.; Hopman, M.T.E.
2007Augmented hyperaemia and reduced tissue injury in response to ischaemia in subjects with the 34C > T variant of the AMPD1 gene.Riksen, N.P.; Franke, B.; Oyen, W.J.G.; Borm, G.F.; Broek, P. van den; Boerman, O.C.; Smits, P.; Rongen, G.A.
2007Local vasoconstriction in spinal cord-injured and able-bodied individuals.Kooijman, M.; Hoog, M. de; Rongen, G.A.; Kuppevelt, H.J.M. van; Smits, P.; Hopman, M.T.E.
2007Acute elevation of plasma non-esterified fatty acids increases pulse wave velocity and induces peripheral vasodilation in humans in vivo.Riksen, N.P.; Bosselaar, M.; Bakker, S.J.; Heine, R.J.; Rongen, G.A.; Tack, C.J.J.; Smits, P.
2007A causal role for endothelin-1 in the vascular adaptation to skeletal muscle deconditioning in spinal cord injury.Thijssen, D.H.J.; Ellenkamp, R.; Kooijman, M.; Pickkers, P.; Rongen, G.A.; Hopman, M.T.E.; Smits, P.
2007Interaction study of the combined use of paroxetine and fosamprenavir-ritonavir in healthy subjects.Lee, M.J. van der; Blenke, A.A.M.; Rongen, G.A.; Wissen, C.P.W.G.M. van; Koopmans, P.P.; Pharo, C.; Burger, D.M.
2006The nonspecific anti-inflammatory therapy with methotrexate for patients with chronic heart failure.Riksen, N.P.; Smits, P.; Rongen, G.A.

1 2 next

 

  DSpace Software Copyright © 2002-2011  Duraspace - Feedback